Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Condylomata acuminata--topical and systemic interferon therapy].

G Fierlbeck1, H Breuninger, B Fierlbeck

  • 1Hautklinik, Universität Tübingen.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|January 1, 1991
PubMed
Summary

Systemic interferon gamma showed moderate efficacy for treating recurrent warts, with higher doses yielding better results. Topical interferon beta was ineffective for wart management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-dimensional histology vs. serial section histology in the treatment of primary basal cell carcinoma: a randomized, prospective, blinded study of 569 tumours.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Manufacture and use of tumescence solution meeting hospital-required hygiene conditions - practical implications.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Tumescent local anaesthesia for early dermatosurgery in infants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative bleeding - a DESSI study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Context:

  • Recurrent genital warts pose a therapeutic challenge.
  • Interferons (IFNs) are cytokines with antiviral and immunomodulatory properties.
  • Previous studies explored IFN efficacy in treating various viral infections.

Purpose:

  • To evaluate the therapeutic potential of systemic interferon gamma and topical interferon beta in managing recurrent genital warts.
  • To compare the efficacy of different dosages of systemic interferon gamma as monotherapy.
  • To assess the role of adjuvant interferon gamma following surgical treatment.

Summary:

  • Topical interferon beta gel demonstrated no significant effect as monotherapy or adjuvant treatment for genital warts.
  • Systemic interferon gamma monotherapy showed response rates of 45% (100 mcg) and 57% (200 mcg).

Related Experiment Videos

  • Adjuvant interferon gamma reduced recurrence rates in patients with normal immune status after surgery, but not in those with prolonged disease or immunodeficiency.

    • Impact:

    • Systemic interferon gamma may offer a treatment option for recurrent warts, particularly at higher doses.
    • Interferon beta gel is not recommended for genital wart treatment.
    • Further research is needed to optimize interferon therapy for specific patient populations.